Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP & President, CVS Pharmacy | April 01, 2019 | April 03, 2019 |
| SYSCO CORPSYY · Entity 2003 | Director · Chair and CEO | September 01, 2026 | September 03, 2026 |
| TAPESTRY, INC.TPR · Entity 2309 | Director | November 13, 2025 | November 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2019 · Filed April 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,237 |
Reported balance
After 2019-04-01 transaction · row 1
1 source rowRow 1 · 2019-04-01 · Tax withholding · Disposed 1,109 · Balance 15,237 F1: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 202,007 |
Reported balance
After 2019-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-04-01 · Grant · Acquired 202,007 · Balance 202,007 F2: Option becomes exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.29 · Expires 2021-04-01 | Direct | 9,442 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 9,442 F3: Option became exercisable in four equal annual installments beginning on 4/1/2015. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $102.26 · Expires 2022-04-01 | Direct | 17,822 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 17,822 F4: Option became exercisable in four equal annual installments beginning on 4/1/2016. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 17,611 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 17,611 F5: Option became exercisable in four equal annual installments beginning on 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 30,169 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 30,169 F6: Option became exercisable in four equal annual installments beginning on 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 87,575 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 87,575 F7: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 6,911 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 6,911 |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan.
F2: Option becomes exercisable in four equal annual installments, commencing 4/1/2020.
F3: Option became exercisable in four equal annual installments beginning on 4/1/2015.
F4: Option became exercisable in four equal annual installments beginning on 4/1/2016.
F5: Option became exercisable in four equal annual installments beginning on 4/1/2017.
F6: Option became exercisable in four equal annual installments beginning on 4/3/2018.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2019.
SYSCO CORP
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 552,923.393 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 84,581 · Balance 552,923.393 F1: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2: One-third of the restricted stock units shall vest in equal installments on 09/01/2027, 09/01/2028 and 09/01/2029, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan.
F2: One-third of the restricted stock units shall vest in equal installments on 09/01/2027, 09/01/2028 and 09/01/2029, respectively.
TAPESTRY, INC.
Report date November 13, 2025 · Filed November 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,347 |
Reported balance
After 2025-11-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-11-13 · Grant · Acquired 1,985 · Balance 7,347 F1: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 13, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 13, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 20:46 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 84,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001741853-26-000009 · wk-form4_1788468412.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 552,923.393 F1 · shares: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · price: One-third of the restricted stock units shall vest in equal installments on 09/01/2027, 09/01/2028 and 09/01/2029, respectively. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 20:46 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 12,796 | $83.06 | $1,062,835.76 |
DisclosureSEC source: 0001741853-26-000007 · wk-form4_1787690786.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 468,342.393 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:42 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 6,309 | $84.29 | $531,785.61 |
DisclosureSEC source: 0001741853-26-000005 · wk-form4_1786567317.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 481,138.393 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 14,503 | $84.71 | $1,228,549.13 |
DisclosureSEC source: 0001741853-26-000003 · wk-form4_1785875407.xml · nonDerivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487,447.393 F2 · shares: These shares were withheld upon the vesting of performance share units to pay tax withholding obligations. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 36,855.34 | $84.71 | $3,122,015.85 |
DisclosureSEC source: 0001741853-26-000003 · wk-form4_1785875407.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,950.393 F1 · shares: Shares received upon the vesting of performance share units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors (the "Committee") pursuant to the 2018 Omnibus Incentive Plan. These performance share units were granted by the Committee in August 2023. The number of shares of common stock received upon the vesting of these performance share units was determined based upon the Company's performance with regard to pre-established financial performance metrics for the performance period from fiscal 2024 to fiscal 2026. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:43 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 1,985 | $100.76 | $200,008.60 |
DisclosureSEC source: 0001225208-25-009186 · doc4.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,347 F1 · security: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 13, 2026. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:09 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 3,405 | $80.47 | $274,000.35 |
DisclosureSEC source: 0000096021-25-000124 · wk-form4_1757020139.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,095.053 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 22, 2025 Filed Aug 25, 2025 22:40 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 6,483 | $80.98 | $524,993.34 |
DisclosureSEC source: 0000096021-25-000113 · wk-form4_1756161600.xml · nonDerivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 468,500.053 F3 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 21, 2025 Filed Aug 25, 2025 22:40 UTC | SYSCO CORP SYY · Entity 2003 | GrantStock Options (Right to buy) · Derivative | 128,039 | $0.00 Strike: $80.98 | $0.00 |
DisclosureSEC source: 0000096021-25-000113 · wk-form4_1756161600.xml · derivative · entry 3 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,039 Underlying: Common Stock · 128,039 shares Expires 2035-08-20 F5 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F4 · derivative.exercise_date: One-third of the shares covered by the grant vest and are exercisable on 8/21/2026, 8/21/2027 and 8/21/2028, respectively. No options may be exercised prior to 8/21/2026. Options will expire on 8/20/2035. Read SEC document |
| August 21, 2025 Filed Aug 25, 2025 22:40 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 48,122 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-25-000113 · wk-form4_1756161600.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,983.053 F1 · shares: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · price: One-third of the restricted stock units shall vest in equal installments on 08/21/2026, 08/21/2027 and 08/21/2028, respectively. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 21:39 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 6,309 | $80.65 | $508,820.85 |
DisclosureSEC source: 0000096021-25-000086 · wk-form4_1755034781.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 426,861.053 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| July 31, 2025 Filed Aug 1, 2025 22:53 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 15,561 | $80.11 | $1,246,591.71 |
DisclosureSEC source: 0000096021-25-000075 · wk-form4_1754088814.xml · nonDerivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,170.053 F2 · shares: These shares were withheld upon the vesting of performance share units to pay tax withholding obligations. Read SEC document |
| July 31, 2025 Filed Aug 1, 2025 22:53 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 39,544.758 | $80.11 | $3,167,930.56 |
DisclosureSEC source: 0000096021-25-000075 · wk-form4_1754088814.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,731.053 F1 · shares: Shares received upon the vesting of performance share units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors (the "Committee") pursuant to the 2018 Omnibus Incentive Plan. These performance share units were granted by the Committee in August 2022. The number of shares of common stock received upon the vesting of these performance share units was determined based upon the Company's performance with regard to pre-established financial performance metrics for the performance period from fiscal 2023 to fiscal 2025. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 21:38 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 3,459 | $57.82 | $199,999.38 |
DisclosureSEC source: 0001225208-24-010001 · doc4.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,290 F1 · security: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 14, 2025. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 21:08 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 6,811 | $77.97 | $531,053.67 |
DisclosureSEC source: 0000096021-24-000134 · wk-form4_1725570500.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,186.295 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 21:13 UTC | SYSCO CORP SYY · Entity 2003 | GrantStock Options (Right to buy) · Derivative | 130,140 | $0.00 Strike: $76.54 | $0.00 |
DisclosureSEC source: 0000096021-24-000111 · wk-form4_1724447605.xml · derivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,140 Underlying: Common Stock · 130,140 shares Expires 2034-08-20 F4 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F3 · derivative.exercise_date: One-third of the shares covered by the grant vest and are exercisable on 8/21/2025, 8/21/2026 and 8/21/2027, respectively. No options may be exercised prior to 8/21/2025. Options will expire on 8/20/2034. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 21:13 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 49,420 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-24-000111 · wk-form4_1724447605.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415,997.295 F1 · shares: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · price: One-third of the restricted stock units shall vest in equal installments on 08/21/2025, 08/21/2026 and 08/21/2027, respectively. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 21:44 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 6,309 | $75.63 | $477,149.67 |
DisclosureSEC source: 0000096021-24-000086 · wk-form4_1723585481.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,577.295 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 01, 2024 Filed Aug 2, 2024 21:29 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 21,024 | $76.44 | $1,607,074.56 |
DisclosureSEC source: 0000096021-24-000064 · wk-form4_1722634153.xml · nonDerivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,886.295 F2 · shares: These shares were withheld upon the vesting of performance share units to pay tax withholding obligations. Read SEC document |
| August 01, 2024 Filed Aug 2, 2024 21:29 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 53,426.441 | $76.44 | $4,083,917.15 |
DisclosureSEC source: 0000096021-24-000064 · wk-form4_1722634153.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 393,910.295 F1 · shares: Shares received upon the vesting of performance share units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors (the "Committee") pursuant to the 2018 Omnibus Incentive Plan. These performance share units were granted by the Committee in August 2021. The number of shares of common stock received upon the vesting of these performance share units was determined based upon the Company's performance with regard to pre-established financial performance metrics for the performance period from fiscal 2022 to fiscal 2024. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:08 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantStock Option · Derivative | 5,280 | $0.00 Strike: $47.53 | $0.00 |
DisclosureSEC source: 0001225208-24-003403 · doc4.xml · derivative · entry 2 Hourican Kevin · CIK 0001741853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,280 Underlying: Common Stock · 5,280 shares Expires 2034-03-01 F2 · security: All of these securities acquired were issued under the Issuer's Stock Incentive Plan. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:08 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 1,788 | $47.53 | $84,983.64 |
DisclosureSEC source: 0001225208-24-003403 · doc4.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,788 F1 · security: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on March 1, 2025. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 21:04 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 11,255 | $69.65 | $783,910.75 |
DisclosureSEC source: 0000096021-23-000124 · wk-form4_1694034252.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,483.854 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 10, 2023 Filed Aug 11, 2023 21:37 UTC | SYSCO CORP SYY · Entity 2003 | GrantStock Options (Right to buy) · Derivative | 124,869 | $0.00 Strike: $74.85 | $0.00 |
DisclosureSEC source: 0000096021-23-000097 · wk-form4_1691789828.xml · derivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,869 Underlying: Common Stock · 124,869 shares Expires not disclosed F4 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F3 · derivative.expiration_date: One-third of the shares covered by the grant vest and are exercisable on 8/10/2024, 8/10/2025 and 8/10/2026, respectively. No options may be exercised prior to 8/10/2024. Options will expire on 8/9/2033. Read SEC document |
| August 10, 2023 Filed Aug 11, 2023 21:37 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 48,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-23-000097 · wk-form4_1691789828.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,738.854 F1 · shares: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · price: One-third of the restricted stock units shall vest in equal installments on 08/10/2024, 08/10/2025 and 08/10/2026, respectively. Read SEC document |
| October 24, 2022 Filed Oct 25, 2022 21:07 UTC | SYSCO CORP SYY · Entity 2003 | Exercise / conversionStock Options (Right to buy) · Derivative | 75,019 | $0.00 Strike: $58.08 | $0.00 |
DisclosureSEC source: 0000096021-22-000193 · wf-form4_166673206196734.xml · derivative · entry 3 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,019 Underlying: Common Stock · 75,019 shares Expires 2030-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F3 · derivative.exercise_date: Options are fully exercisable. Read SEC document |
| October 24, 2022 Filed Oct 25, 2022 21:07 UTC | SYSCO CORP SYY · Entity 2003 | SaleCommon Stock | 75,019 | $81.22 | $6,093,043.18 |
DisclosureSEC source: 0000096021-22-000193 · wf-form4_166673206196734.xml · nonDerivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,642.854 F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average sale price per share of the 75,019 shares sold on this date. These shares were sold in multiple transactions at prices ranging from $80.37 to $81.82. The Reporting Person undertakes to provide Sysco Corporation, any security holder of Sysco Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding number of shares sold at each separate price within the ranges set forth in the footnote of this Form 4. Read SEC document |
| October 24, 2022 Filed Oct 25, 2022 21:07 UTC | SYSCO CORP SYY · Entity 2003 | Exercise / conversionCommon Stock | 75,019 | $58.08 | $4,357,103.52 |
DisclosureSEC source: 0000096021-22-000193 · wf-form4_166673206196734.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,661.854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:50 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 7,850 | $82.22 | $645,427.00 |
DisclosureSEC source: 0000096021-22-000157 · wf-form4_166215181200175.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,642.854 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 21:22 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock · Derivative | 136,363 | $0.00 Strike: $85.57 | $0.00 |
DisclosureSEC source: 0000096021-22-000129 · wf-form4_166094412870922.xml · derivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,363 Underlying: Common Stock · 136,363 shares Expires 2032-08-17 F4 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F3 · derivative.exercise_date: One-third of the shares covered by the grant vest and are exercisable on 08/18/2023, 08/18/2024 and 08/18/2025, respectively. No options may be exercised prior to 08/18/2023. Options will expire on 08/17/2032. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 21:22 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 25,961 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-22-000129 · wf-form4_166094412870922.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,492.854 F1 · shares: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · price: One-third of the restricted stock units shall vest in equal installments on 09/01/2023, 09/01/2024 and 09/01/2025, respectively. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:16 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 74,338 | $87.28 | $6,488,220.64 |
DisclosureSEC source: 0000096021-22-000109 · wf-form4_165947492958596.xml · nonDerivative · entry 4 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,531.854 F2 · shares: These shares were withheld upon the vesting of performance share units to pay tax withholding obligations. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:16 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 188,912.46 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-22-000109 · wf-form4_165947492958596.xml · nonDerivative · entry 3 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,869.854 F3 · shares: Shares received upon the vesting of performance share units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors (the "Committee") pursuant to the 2018 Omnibus Incentive Plan. These performance share units were granted by the Committee in June 2021 and has a two-year holding period at the time of vesting. The number of shares of common stock received upon the vesting of these performance share units was determined based upon the Company's performance with regard to pre-established financial performance metrics for the performance period from fiscal 2021 to fiscal 2022. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:16 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 53,515 | $87.28 | $4,670,789.20 |
DisclosureSEC source: 0000096021-22-000109 · wf-form4_165947492958596.xml · nonDerivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,957.394 F2 · shares: These shares were withheld upon the vesting of performance share units to pay tax withholding obligations. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:16 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 135,995.394 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-22-000109 · wf-form4_165947492958596.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,472.394 F1 · shares: Shares received upon the vesting of performance share units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors (the "Committee") pursuant to the 2018 Omnibus Incentive Plan. These performance share units were granted by the Committee in August 2020. The number of shares of common stock received upon the vesting of these performance share units was determined based upon the Company's performance with regard to pre-established financial performance metrics for the performance period from fiscal 2021 to fiscal 2022. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:11 UTC | SYSCO CORP SYY · Entity 2003 | Exercise / conversionStock Options (Right to buy) · Derivative | 75,018 | $0.00 Strike: $58.08 | $0.00 |
DisclosureSEC source: 0000096021-22-000072 · wf-form4_164971144316643.xml · derivative · entry 3 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,038 Underlying: Common Stock · 75,018 shares Expires 2030-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · derivative.exercise_date: Options are fully exercisable. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:11 UTC | SYSCO CORP SYY · Entity 2003 | SaleCommon Stock | 75,018 | $86.00 | $6,451,548.00 |
DisclosureSEC source: 0000096021-22-000072 · wf-form4_164971144316643.xml · nonDerivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,477 F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:11 UTC | SYSCO CORP SYY · Entity 2003 | Exercise / conversionCommon Stock | 75,018 | $58.08 | $4,357,045.44 |
DisclosureSEC source: 0000096021-22-000072 · wf-form4_164971144316643.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:11 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 4,444 | $79.65 | $353,964.60 |
DisclosureSEC source: 0000096021-21-000099 · wf-form4_163070344676960.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,477 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 21:22 UTC | SYSCO CORP SYY · Entity 2003 | GrantStock Options (Right to buy) · Derivative | 181,268 | $0.00 Strike: $76.94 | $0.00 |
DisclosureSEC source: 0000096021-21-000071 · wf-form4_162975370520602.xml · derivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,268 Underlying: Common Stock · 181,268 shares Expires 2031-08-18 F4 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F3 · derivative.exercise_date: One-third of the shares covered by the grant vest and are exercisable on 08/19/2022, 08/19/2023 and 08/19/2024, respectively. No options may be exercised prior to 08/19/2022. Options will expire on 08/18/2031. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 21:22 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 25,960 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-21-000071 · wf-form4_162975370520602.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,921 F1 · shares: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · price: One-third of the restricted stock units shall vest in equal installments on 09/01/2022, 09/01/2023 and 09/01/2024, respectively. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 21:23 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 10,742 | $74.20 | $797,056.40 |
DisclosureSEC source: 0000096021-21-000065 · wf-form4_162802579976845.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,961 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 22:10 UTC | SYSCO CORP SYY · Entity 2003 | Tax withholdingCommon Stock | 10,767 | $71.51 | $769,948.17 |
DisclosureSEC source: 0000096021-21-000013 · wf-form4_161230383638248.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,703 F1 · shares: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 21:29 UTC | SYSCO CORP SYY · Entity 2003 | GrantStock Options (Right to buy) · Derivative | 225,056 | $0.00 Strike: $58.08 | $0.00 |
DisclosureSEC source: 0000096021-20-000081 · wf-form4_159804534553270.xml · derivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,056 Underlying: Common Stock · 225,056 shares Expires 2030-08-19 F4 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F3 · derivative.exercise_date: One-third of the shares covered by the grant vest and are exercisable on 08/20/2021, 08/20/2022 and 08/20/2023, respectively. No options may be exercised prior to 08/20/2021. Options will expire on 08/19/2030. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 21:29 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 33,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-20-000081 · wf-form4_159804534553270.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,470 F1 · shares: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · price: One-third of the restricted stock units shall vest in equal installments on 09/01/2021, 09/01/2022 and 09/01/2023, respectively. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 22:12 UTC | SYSCO CORP SYY · Entity 2003 | GrantStock Options (Right to buy) · Derivative | 683,303 | $0.00 Strike: $76.27 | $0.00 |
DisclosureSEC source: 0000096021-20-000023 · wf-form4_158171833436371.xml · derivative · entry 2 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,303 Underlying: Common Stock · 683,303 shares Expires 2030-02-11 F3 · price: Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. F2 · derivative.exercise_date: One-third of the shares covered by the grant vest and are exercisable on August 21, 2020, August 21, 2021 and August 21, 2022, respectively. No options may be exercised prior to August 21, 2020. Options will expire on February 11, 2030. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 22:12 UTC | SYSCO CORP SYY · Entity 2003 | GrantCommon Stock | 54,595 | $0.00 | $0.00 |
DisclosureSEC source: 0000096021-20-000023 · wf-form4_158171833436371.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,595 F1 · price: Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. This award of restricted stock units was made in connection with the reporting person's hiring as the Company's President and Chief Executive Officer, effective February 1, 2020. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 202,007 | $54.19 Strike: $54.19 | $10,946,759.33 |
DisclosureSEC source: 0001127602-19-014660 · form4.xml · derivative · entry 3 Hourican Kevin · CIK 0001741853 · EVP & President, CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,007 Underlying: Common Stock · 202,007 shares Expires 2029-04-01 F2 · derivative.exercise_price: Option becomes exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,109 | $54.19 | $60,096.71 |
DisclosureSEC source: 0001127602-19-014660 · form4.xml · nonDerivative · entry 1 Hourican Kevin · CIK 0001741853 · EVP & President, CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,237 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 9,467 | $57.83 | $547,476.61 |
DisclosureSEC source: 0001127602-19-009282 · form4.xml · nonDerivative · entry 2 Hourican Kevin · CIK 0001741853 · EVP & President, CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,778 F2 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.